Alpha IVF Group Berhad (KLSE:ALPHA)
Malaysia · Delayed Price · Currency is MYR 0.2400
-0.0050 (-2.04%)
At close: Sep 21, 2026
Alpha IVF Group Berhad Revenue
In the fiscal year ending May 31, 2026, Alpha IVF Group Berhad had annual revenue of 198.59M MYR with 12.30% growth. Alpha IVF Group Berhad had revenue of 52.07M in the quarter ending May 31, 2026, with 4.13% growth.
Revenue
198.59M
Revenue Growth
+12.30%
P/S Ratio
5.85
Revenue / Employee
n/a
Employees
198
Market Cap
1.16B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 31, 2026 | 198.59M | 21.75M | 12.30% |
| May 31, 2025 | 176.84M | 9.26M | 5.52% |
| May 31, 2024 | 167.59M | 30.11M | 21.90% |
| May 31, 2023 | 137.48M | 46.39M | 50.92% |
| May 31, 2022 | 91.09M | 29.03M | 46.78% |
| May 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Duopharma Biotech Berhad | 929.41M |
| MKH Berhad | 796.00M |
| Supermax Corporation Berhad | 737.06M |
| Ajinomoto (Malaysia) Berhad | 708.21M |
| Crescendo Corporation Berhad | 694.09M |
| BM GreenTech Berhad | 637.27M |
| Keyfield International Berhad | 372.50M |
| NCT Alliance Berhad | 365.40M |